Madrigal Pharmaceuticals(CH:YDO1)
CH:YDO1
Madrigal Pharmaceuticals earnings date
Madrigal Pharmaceuticals (YDO1) Q2 2026 Earnings Report
0 Followers
CH:YDO1 Q2 2026 EPS Results
- Actual EPS
- -CHF 1.66
- Consensus EPS
- -CHF 2.23
- Beat/Miss
- Beat by +CHF 0.57
- One Year Ago EPS
- -CHF 1.58
CH:YDO1 Q2 2026 Revenue Results
- Actual Revenue
- CHF 303.15M
- Expected Revenue
- CHF 293.06M
- Beat/Miss
- Beat by +CHF 10.09M
- YoY Revenue Growth
- +71.17%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/30/2026
- Time
- Before Open
- Conference Call
- Thursday, July 30, 2026
CH:YDO1 Upcoming Earnings
Madrigal Pharmaceuticals's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:YDO1 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:YDO1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | 1.19- | -2.14 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.721.52 | -4.23 | 136.02% (+5.75) | |
| Jul 30, 2026 | 2026 (Q2) | -2.23-1.66 | -1.58 | -4.74% (-0.07) | |
| May 06, 2026 | 2026 (Q1) | -3.52-2.70 | -2.76 | 2.11% (+0.06) | |
| Feb 19, 2026 | 2025 (Q4) | -0.74-2.14 | -2.26 | 5.17% (+0.12) | |
| Nov 04, 2025 | 2025 (Q3) | -1.90-4.23 | -4.09 | -3.25% (-0.13) | |
| Aug 05, 2025 | 2025 (Q2) | -2.96-1.58 | -5.91 | 73.24% (+4.33) | |
| May 01, 2025 | 2025 (Q1) | -3.12-2.76 | -6.14 | 55.01% (+3.38) | |
| Feb 26, 2025 | 2024 (Q4) | -3.26-2.26 | -4.73 | 52.29% (+2.47) | |
| Oct 31, 2024 | 2024 (Q3) | -5.62-4.09 | -4.44 | 7.87% (+0.35) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


